Date: {{$ActivityAssignDate}}

Dear Dr. {{ $doctorName }},

Subject: A Disease and Management Insight Survey on Urticaria among Healthcare practitioners in India

Chronic urticaria is one of the most frequent skin disorders. It is one of the most prevalent dermatology diseases in India and has a profound effect on quality of life and causes immense distress to the patients, necessitating effective treatment. Various clinical studies and research have been done in last few years on the treatment regimens, usage of anti-histamines in urticaria, in which up dosing one of the latest & revolutionary advancement is observed across the globe.

Guideline recommends use of second generation H1 antihistamines as the first line treatment and the dose can be increase to meet the expected results. There are numerous studies showing the benefit of a higher dosage of antihistamines in individual patients. These studies suggest that the majority of patients with urticaria not responding to single dose will profit from up-dosing of antihistamines. Further in case of non-response to the higher dose of antihistamine, cyclosporine and omalizumab are other treatment options. Assessment of treatment can be done with urticaria control test (UCT).

There is limited data on the epidemiology and treatment practices of urticaria among health care practitioners in India. This survey has been undertaken to assess Disease and Management Insight Survey on Urticaria among Healthcare practitioners in India.

As you will be spending some extra time to give your feedback on the questionnaire based on your clinical experience, we offer to pay you by cheque a professional fee of Rs {{$contractAmount}}, on receiving the completed Survey Questionnaire Form from you.

We trust you and we are partners in promoting safe and effective drug therapy. In that spirit we hope you will consent to participate in this study. If you do, please sign and return the enclosed reply along with your visiting card for accuracy of records.